These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13173294)

  • 1. [Effect of hydrazinophthalazine on intrarenal hemodynamics in essential hypertension].
    DOERING P; KOCH R; KUHNS K; SCHWAB M
    Dtsch Arch Klin Med; 1954; 201(1):44-56. PubMed ID: 13173294
    [No Abstract]   [Full Text] [Related]  

  • 2. Further cardiovascular and renal hemodynamic studies following the administration of hydralazine (1-hydrazinophthalazine) and the effect of ganglionic blockade with hexamethonium on these responses.
    MOYER JH; HUGGINS RA; HANDLEY CA
    J Pharmacol Exp Ther; 1953 Oct; 109(2):175-82. PubMed ID: 13097349
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of oral 1-hydrazinophthalazine therapy on renal function in essential vascular hypertension.
    MADER IJ; ISERI L
    Am Heart J; 1955 Oct; 50(4):556-66. PubMed ID: 13258483
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of 1-hydrazinophthalazine upon coronary hemodynamics and myocardial oxygen metabolism in essential hypertension.
    ROWE GG; HUSTON JH; MAXWELL GM; WEINSTEIN AB; TUCHMAN H; CRUMPTON CW
    J Clin Invest; 1955 May; 34(5):696-9. PubMed ID: 14367526
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.
    ROWE GG; HUSTON JH; MAXWELL GM; CROSLEY AP; CRUMPTON CW
    J Clin Invest; 1955 Jan; 34(1):115-20. PubMed ID: 13221661
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of hydrazinophthalazine in essential hypertension].
    VIZZINI AA
    Hospital (Rio J); 1953 Dec; 44(6):775-82. PubMed ID: 13151634
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal and hypotensive effects of acute and chronic oral treatment with 1-hydrazinophthalazine (apresoline) in hypertension.
    VANDERKOLK K; DONTAS AS; HOOBLER SW
    Am Heart J; 1954 Jul; 48(1):95-101. PubMed ID: 13171330
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamics changes after acute and chronic application of hydrazinophthalazine preparations].
    HOFMANN-CREDNER D; SIEDEK H
    Z Kreislaufforsch; 1954 Apr; 43(7-8):217-24. PubMed ID: 13179742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of hydrazinophthalazine on arterial pressure in hypertension].
    PLESCH SA; CAPRIS TA
    Prensa Med Argent; 1953 Apr; 40(15):882-4. PubMed ID: 13073889
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of hexemethonium chloride and 1-hydrazinophthalazine in the treatment of hypertension.
    LINLEY DM; ESKWITH IS
    Conn State Med J; 1953 Jun; 17(6):498-500. PubMed ID: 13060020
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of hypertension with hexamethonium and hydrazinophthalazine (apresoline).
    CUBBERLY RB; WIESEL LL; LAMB AE
    Brooklyn Hosp J; 1953; 11(3 3rd Quarter):125-34. PubMed ID: 13094157
    [No Abstract]   [Full Text] [Related]  

  • 12. Dibenzyline: results of therapy in patients with hypertension and a comparison with hexamethonium, 1-hydrazinophthalazine and semipurified extracts of veratrum.
    MILLER SI; FORD RV; MOYER JH
    N Engl J Med; 1953 Apr; 248(14):576-83. PubMed ID: 13037001
    [No Abstract]   [Full Text] [Related]  

  • 13. [1-Hydrazinophthalazine hydrochloride in the treatment of hypertension].
    PICCINELLI O
    Farmaco Sci; 1953; 8(5):294-302. PubMed ID: 13095495
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine].
    PAGE I; TAYLOR RD; CORCORAN AC
    Medizinische; 1952 Nov; 20(48):1516-8. PubMed ID: 13024596
    [No Abstract]   [Full Text] [Related]  

  • 15. 1-Hydrazinophthalazine (apresoline) in hypertension.
    HARRIS E; TURNER R
    Lancet; 1954 Feb; 266(6809):429-33. PubMed ID: 13131873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hypertension with hydrazinophthalazine].
    KUHNS K; MEYER-HOFMANN G; HOPFNER K
    Klin Wochenschr; 1953 Aug; 31(29-30):690-4. PubMed ID: 13097882
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hydrazinophthalazine in hypertension; clinical studies].
    ESSELLIER AF; LUSCHER W; MORANDI L
    Schweiz Med Wochenschr; 1953 Apr; 83(14):340-5. PubMed ID: 13076044
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of 1-hydrazinophthalazine on cerebral blood flow, vascular resistance, oxygen uptake and jugular oxygen tension in hypertensive subjects.
    HAFKENSCHIEL JH; FRIEDLAND CK
    J Clin Invest; 1953 Jul; 32(7):655-60. PubMed ID: 13069612
    [No Abstract]   [Full Text] [Related]  

  • 19. The control of hypertension with 1-hydrazinophthalazine (apresoline).
    RIVEN SS; POCOCK DG; KORY RC; ROEHM DC; ANDERSON RS; MENEELY GR
    Am J Med; 1953 Feb; 14(2):160-7. PubMed ID: 13016597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of arterial hypertension with hydrazinophthalazine derivatives].
    ABAZA A; VARROUD-VIAL J
    Bull Mem Soc Med Hop Paris; 1953 May 29-Jun 5; 69(17-18):530-49. PubMed ID: 13082401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.